Most people on Ozempic lose around 12% of their body weight compared to what they’d lose with diet and exercise alone. For someone who weighs 220 pounds, that translates to roughly 26 pounds. But your results depend heavily on your dose, how long you stay on the medication, and what happens with your lifestyle alongside it.
What the Clinical Trials Show
A large meta-analysis of randomized controlled trials found that semaglutide (Ozempic’s active ingredient) produced an average weight loss of 12.1% of body weight, or about 27 pounds, compared to placebo. Those are averages, though, and individual results vary widely. About one-third of participants in clinical trials lost 20% or more of their body weight, while others lost considerably less.
Dose matters. At the 0.5 mg weekly dose, participants lost about 5.7 pounds more than placebo. At the 1 mg dose, that gap widened to 7.7 pounds. Ozempic’s maximum approved dose is 2 mg per week, though your doctor will start you at 0.25 mg and increase gradually over several months to reduce side effects like nausea.
It’s worth noting that Ozempic is FDA-approved for type 2 diabetes, not specifically for weight loss. Its sister drug Wegovy contains the same ingredient at a higher dose and carries the weight management label. In practice, many people are prescribed Ozempic off-label for weight loss, and the results overlap significantly.
A Realistic Month-by-Month Timeline
Weight loss on Ozempic is not instant. The first month is a dose-escalation period at 0.25 mg, which is too low to produce significant fat loss. Most people notice reduced appetite during this phase but minimal change on the scale.
By months two and three, once you’ve moved to a maintenance dose, average weight loss reaches about 4 to 6% of body weight. For a 200-pound person, that’s 8 to 12 pounds. At the six-month mark, clinical data shows losses in the range of 6 to 10%. By one year, participants in the STEP 5 trial had lost an average of 14 to 16% of their body weight, with over a third exceeding 20% loss.
The trajectory is steepest in the first six months, then gradually tapers. Most people hit a plateau around 60 weeks. At that point, your body has adjusted: a lighter frame burns fewer calories at rest, so your metabolism eventually matches your reduced food intake. This isn’t the drug failing. It’s basic energy balance reasserting itself at a new, lower weight.
Why Some People Lose More Than Others
Starting weight is one factor. People with more weight to lose often see larger absolute numbers, though the percentage tends to be fairly consistent across body sizes. How well you tolerate higher doses also plays a role. If nausea or other gastrointestinal side effects keep you at a lower dose, your results will likely land on the lower end of the range.
Diet and exercise still matter on Ozempic. The drug works primarily by reducing appetite and slowing stomach emptying, so you naturally eat less. But if your food choices remain calorie-dense or you’re largely sedentary, the gap between your results and the trial averages can be significant. Participants in clinical trials also received lifestyle counseling, which likely contributed to the reported outcomes.
How Ozempic Compares to Mounjaro
If you’re weighing your options, Mounjaro (tirzepatide) consistently outperforms Ozempic in head-to-head data. In the SURPASS-2 trial, Mounjaro users lost between 17 and 25 pounds on average, compared to 13 pounds for those on Ozempic. A large real-world study of over 41,000 adults found that 81.8% of Mounjaro patients lost at least 5% of their body weight within a year, versus 66.5% on Ozempic. At 12 months, the difference favored Mounjaro by about 6.9 percentage points.
In the SURMOUNT-5 trial comparing the higher-dose versions of both drugs (Zepbound vs. Wegovy), tirzepatide produced roughly 20% weight loss at 72 weeks compared to about 14% for semaglutide. Mounjaro targets two gut hormones instead of one, which appears to drive the extra weight loss. That said, Ozempic has a longer track record and remains effective for the majority of users.
What Happens If You Stop
This is the part most people don’t think about early enough. A systematic review published in The Lancet found that within one year of stopping semaglutide, people regained 60% of the weight they had lost during treatment. So if you lost 30 pounds, you could expect to regain about 18 of those pounds within a year of discontinuing.
This happens because the drug suppresses appetite through hormonal signaling, and that suppression disappears when the medication leaves your system. Hunger returns to baseline levels, and without deliberate changes to eating habits and activity, weight creeps back. Many doctors now consider these medications long-term or even indefinite treatments for that reason, similar to how blood pressure medication manages but doesn’t cure hypertension.
Breaking Through a Plateau
If your weight loss stalls after several months, it doesn’t necessarily mean the medication has stopped working. Plateaus typically occur once your body’s calorie burn matches your reduced intake. Your metabolism slows as you get lighter, which is a normal physiological response, not a failure of willpower or medication.
A dose increase, if you haven’t yet reached the maximum, is one option your prescriber may consider. Beyond that, adding structured exercise (particularly strength training, which preserves muscle and supports metabolism) and reassessing portion sizes can help restart progress. Some people also find that the plateau represents a stable, healthier weight that their body is naturally settling into.